This thesis describes the process of the development towards a microfluidic platform to perform apoptosis studies on chip in real-time at a single-cell level. The requirements for such cell-based assays are discussed as well as the advantages of using microfluidics for cellular analysis. Our main interest is focused on breast cancer cells. Ultimately, this microfluidic chip has to function as a new analytical device for the clinic to provide patients with the best individual therapy.
|Award date||8 Jun 2007|
|Place of Publication||Zutphen|
|Publication status||Published - 8 Jun 2007|